查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
制酸劑的全球市場(2023年～2027年):規模、預測、產業趨勢、成長、通貨膨脹的影響、機會、企業分析
市場調查報告書
商品編碼
1163931

制酸劑的全球市場(2023年～2027年):規模、預測、產業趨勢、成長、通貨膨脹的影響、機會、企業分析

Antacids Market, Size, Global Forecast 2023-2027, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis
出版日期: | 出版商: Renub Research | 英文 115 Pages | 商品交期: 最快1-2個工作天內

價格

全球制酸劑的市場規模，預計2022年～2027年之間以3.78％的年複合成長率擴大，2027年達到105億美元。

制酸劑市場的發展很大程度上是由於公司重組業務並從COVID-19的影響中恢復過來。COVID-19導致了限制性遏制措施，包括遠程工作、社交距離和商業關閉，給運營帶來了挑戰。

文書工作，睡眠的品質低，不規則的飲食等的生活方式的惡化，提高胃的酸性度，造成胃食道逆流症，成為對制酸劑市場成長不可或缺的要素。

本報告提供全球制酸劑市場調查，市場概要，促進因素和課題，市場佔有率，各藥物類別、劑型、流通管道、地區市場，主要企業簡介等彙整資訊。

目錄

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 促進因素
  • 課題

第5章 全球制酸劑市場

第6章 全球制酸劑市場:市場佔有率

  • 各類藥物
  • 各劑型
  • 各流通管道
  • 各地區

第7章 全球制酸劑市場:各類藥物

  • 質子幫浦抑制劑
  • H2拮抗劑
  • 酸中和劑

第8章 全球制酸劑市場:各劑型

  • 錠劑
  • 液體
  • 粉末

第9章 全球制酸劑市場:各流通管道

  • 醫院藥局
  • 零售藥局
  • 線上藥局

第10章 全球制酸劑市場:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第11章 企業分析

  • Pfizer Inc
  • GlaxoSmithKline plc.
  • Dr. Reddy's Laboratories Ltd
  • Johnson & Johnson
  • Bayer AG
  • Sanofi
  • Abbott Laboratories

Global Antacids Market will reach US$ 10.50 Billion in 2027 according to Renub Research. Globally, antacids are widely used for treating ulcers, inflammation, dyspepsia discomfort, sore stomach, stomach acid indigestion, and stomach upset. It is an over-the-counter (OTC) medication that neutralizes the acid in the stomach to relieve indigestion and heartburn. Further, they contain ingredients like magnesium hydroxide, sodium bicarbonate, calcium, and aluminum are commonly available in convenient chewable powder, tablets, and liquid forms. They are self-prescribed medications and act by neutralizing the acid in the stomach and inhibiting pepsin.

Antacids Market Size is likely to expand at a CAGR of 3.78 % during 2022 - 2027:

The development in the antacids market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had prior led to restrictive containment measures involving remote working, social distancing, and the closure of commercial activities that resulted in operational challenges.

Poor lifestyle adoptions such as deskbound jobs, poor sleep quality, and irregular dietary habits, which increases the acidity level of the stomach and lead to gastroesophageal reflux disease, are essential drivers for the evolution of the antacids market. As per the American College of Gastroenterology, about 60 million Americans suffer from gastroesophageal reflux disease.

Tablets are Expected to Hold a Major Market Share:

By Dosage Form, Tablet was estimated to be the largest segment. Chewable tablets in different flavors help improve patient adherence to the medication, which in turn is expected to contribute to the segment's growth. In addition, tablets are easy to store and can provide the exact dosage amount to the patients compared to the other dosage forms. According to our research findings Antacids Market Size is likely to expand at a CAGR of 3.78% during 2022 - 2027.

Distribution Channel Insights:

By distribution channel, the market is trifurcated into retail pharmacies, online pharmacies, and hospital pharmacies. Online pharmacy is the fastest-growing segment over the forecast period due to increasing consumer awareness. In addition, people are picking online pharmacies due to lucrative offers, such as price discounts, ease in the availability of drugs, and home delivery services. Furthermore, the increasing adoption of information technology in the healthcare sector aids clinicians in sending prescriptions electronically, which is expected to boost growth.

Based on Region, North America is the most significant market for Antacids:

The North American antacids market is anticipated to grow significantly due to lifestyle changes and the rising geriatric population leading to gastrointestinal problems among the American people. Also, the trend towards self-medication in countries such as the United States is increasing the demand for OTC (over-the-counter) digestive products, such as antacids. As a result, antacids are the most common over-the-counter products in the United States.

Impact of COVID-19 on Antacids market:

Market growth was hampered by declining production, a lockdown, and a labor shortage during the COVID-19 epidemic. As a result, the prices were higher than usual. But due to the rising demand for new antacids, the market will be growing in the coming years. Furthermore, the COVID-19 pandemic caused a transient spike in antacid sales, which led to panic buying among individuals who had severe medical conditions like gastroesophageal reflux disease and obesity. Additionally, it was witnessed that various gastrointestinal medications successfully enhanced the clinical results of hospitalized COVID-19 patients.

Key Players:

Pfizer Inc, GlaxoSmithKline plc., Dr. Reddy's Laboratories Ltd, Johnson & Johnson, Bayer AG, Sanofi, and Abbott Laboratories, are the leading competitors in the Antacids industry. Further, these organizations employ various techniques to drive their company portfolio worldwide, including innovative product releases and R&D.

Renub Research latest report "Antacids Market, Forecast By Drug Class (Proton Pump Inhibitor, H2 Antagonist, Acid Neutralizers), Dosage Form (Tablet, Liquid, Powder), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Region ( North America, Europe, Asia Pacific,South America, Middle East & Africa), Companies (Pfizer Inc, GlaxoSmithKline plc., Dr Reddy's Laboratories Ltd, Johnson & Johnson, Bayer AG, Sanofi, Abbott Laboratories)" provides a detailed analysis of Global Antacids Market.

Drug Class - The market has been studied from 3 viewpoints:

  • 1. Proton Pump Inhibitor
  • 2. H2 Antagonist
  • 3. Acid Neutralizers

Dosage Form - The market has been studied from 3 viewpoints:

  • 1. Tablet
  • 2. Liquid
  • 3. Powder

Distribution Channel - The market has been studied from 3 viewpoints:

  • 1. Hospital Pharmacies
  • 2. Retail Pharmacies
  • 3. Online Pharmacies

By Region - The market has been studied from 5 viewpoints:

  • 1. North America
  • 2. Europe
  • 3. Asia Pacific
  • 4. South America
  • 5. Middle East & Africa

Company Insights:

  • Overview
  • Initiatives/Recent Developments
  • Financial Insight

Companies Covered:

  • 1. Pfizer Inc
  • 2. GlaxoSmithKline plc.
  • 3. Dr Reddy's Laboratories Ltd
  • 4. Johnson & Johnson
  • 5. Bayer AG
  • 6. Sanofi
  • 7. Abbott Laboratories

Table of Contents

1. Introduction

2. Research & Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges

5. Global Antacids Market

6. Market Share - Global Antacids Market

  • 6.1 By Drug Class
  • 6.2 By Dosage Form
  • 6.3 By Distribution Channel
  • 6.4 By Region

7. Drug Class - Global Antacids Market

  • 7.1 Proton Pump Inhibitor
  • 7.2 H2 Antagonist
  • 7.3 Acid Neutralizers

8. Dosage Form - Global Antacids Market

  • 8.1 Tablet
  • 8.2 Liquid
  • 8.3 Powder

9. Distribution Channel - Global Antacids Market

  • 9.1 Hospital Pharmacies
  • 9.2 Retail Pharmacies
  • 9.3 Online Pharmacies

10. Region - Global Antacids Market

  • 10.1 North America
  • 10.2 Europe
  • 10.3 Asia Pacific
  • 10.4 South America
  • 10.5 Middle East & Africa

11. Company Analysis

  • 11.1 Pfizer Inc
    • 11.1.1 Overview
    • 11.1.2 Recent Development
    • 11.1.3 Financial Insights
  • 11.2 GlaxoSmithKline plc.
    • 11.2.1 Overview
    • 11.2.2 Recent Development
    • 11.2.3 Financial Insights
  • 11.3 Dr. Reddy's Laboratories Ltd
    • 11.3.1 Overview
    • 11.3.2 Recent Development
    • 11.3.3 Financial Insights
  • 11.4 Johnson & Johnson
    • 11.4.1 Overview
    • 11.4.2 Recent Development
    • 11.4.3 Financial Insights
  • 11.5 Bayer AG
    • 11.5.1 Overview
    • 11.5.2 Recent Development
    • 11.5.3 Financial Insights
  • 11.6 Sanofi
    • 11.6.1 Overview
    • 11.6.2 Recent Development
    • 11.6.3 Financial Insights
  • 11.7 Abbott Laboratories
    • 11.7.1 Overview
    • 11.7.2 Recent Development
    • 11.7.3 Financial Insights

List of Figures

  • Figure-01: Global - Antacids Market (Billion US$), 2017 - 2022
  • Figure-02: Global - Forecast for Antacids Market (Billion US$), 2023 - 2027
  • Figure-03: Drug Class - Proton Pump Inhibitor Market (Million US$), 2017 - 2022
  • Figure-04: Drug Class - Forecast for Proton Pump Inhibitor Market (Million US$), 2023 - 2027
  • Figure-05: Drug Class - H2 Antagonist Market (Million US$), 2017 - 2022
  • Figure-06: Drug Class - Forecast for H2 Antagonist Market (Million US$), 2023 - 2027
  • Figure-07: Drug Class - Acid Neutralizers Market (Million US$), 2017 - 2022
  • Figure-08: Drug Class - Forecast for Acid Neutralizers Market (Million US$), 2023 - 2027
  • Figure-09: Dosage Form - Tablet Market (Million US$), 2017 - 2022
  • Figure-10: Dosage Form - Forecast for Tablet Market (Million US$), 2023 - 2027
  • Figure-11: Dosage Form - Liquid Market (Million US$), 2017 - 2022
  • Figure-12: Dosage Form - Forecast for Liquid Market (Million US$), 2023 - 2027
  • Figure-13: Dosage Form - Powder Market (Million US$), 2017 - 2022
  • Figure-14: Dosage Form - Forecast for Powder Market (Million US$), 2023 - 2027
  • Figure-15: Distribution Channel - Hospital Pharmacies Market (Million US$), 2017 - 2022
  • Figure-16: Distribution Channel - Forecast for Hospital Pharmacies Market (Million US$), 2023 - 2027
  • Figure-17: Distribution Channel - Retail Pharmacies Market (Million US$), 2017 - 2022
  • Figure-18: Distribution Channel - Forecast for Retail Pharmacies Market (Million US$), 2023 - 2027
  • Figure-19: Distribution Channel - Online Pharmacies Market (Million US$), 2017 - 2022
  • Figure-20: Distribution Channel - Forecast for Online Pharmacies Market (Million US$), 2023 - 2027
  • Figure-21: North America - Antacids Market (Million US$), 2017 - 2022
  • Figure-22: North America - Forecast for Antacids Market (Million US$), 2023 - 2027
  • Figure-23: Europe - Antacids Market (Million US$), 2017 - 2022
  • Figure-24: Europe - Forecast for Antacids Market (Million US$), 2023 - 2027
  • Figure-25: Asia Pacific - Antacids Market (Million US$), 2017 - 2022
  • Figure-26: Asia Pacific - Forecast for Antacids Market (Million US$), 2023 - 2027
  • Figure-27: South America - Antacids Market (Million US$), 2017 - 2022
  • Figure-28: South America - Forecast for Antacids Market (Million US$), 2023 - 2027
  • Figure-29: Middle East & Africa - Antacids Market (Million US$), 2017 - 2022
  • Figure-30: Middle East & Africa - Forecast for Antacids Market (Million US$), 2023 - 2027
  • Figure-31: Pfizer Inc - Global Revenue Market (Billion US$), 2017 - 2022
  • Figure-32: Pfizer Inc - Forecast for Global Revenue Market (Billion US$), 2023 - 2027
  • Figure-33: GlaxoSmithKline plc. - Global Revenue Market (Billion US$), 2017 - 2022
  • Figure-34: GlaxoSmithKline plc. - Forecast for Global Revenue Market (Billion US$), 2023 - 2027
  • Figure-35: Dr. Reddy's Laboratories Ltd - Global Revenue Market (Million US$), 2017 - 2022
  • Figure-36: Dr. Reddy's Laboratories Ltd - Forecast for Global Revenue Market (Million US$), 2023 - 2027
  • Figure-37: Johnson & Johnson - Global Revenue Market (Billion US$), 2017 - 2022
  • Figure-38: Johnson & Johnson - Forecast for Global Revenue Market (Billion US$), 2023 - 2027
  • Figure-39: Bayer AG - Global Revenue Market (Billion US$), 2017 - 2022
  • Figure-40: Bayer AG - Forecast for Global Revenue Market (Billion US$), 2023 - 2027
  • Figure-41: Sanofi - Global Revenue Market (Billion US$), 2017 - 2022
  • Figure-42: Sanofi - Forecast for Global Revenue Market (Billion US$), 2023 - 2027
  • Figure-43: Abbott Laboratories - Global Revenue Market (Billion US$), 2017 - 2022
  • Figure-44: Abbott Laboratories - Forecast for Global Revenue Market (Billion US$), 2023 - 2027

List of Tables

  • Table-01: Global - Antacids Market Share by Drug Class (Percent), 2017 - 2022
  • Table-02: Global - Forecast for Antacids Market Share by Drug Class (Percent), 2023 - 2027
  • Table-03: Global - Antacids Market Share by Dosage Form (Percent), 2017 - 2022
  • Table-04: Global - Forecast for Antacids Market Share by Dosage Form (Percent), 2023 - 2027
  • Table-05: Global - Antacids Market Share by Distribution Channel (Percent), 2017 - 2022
  • Table-06: Global - Forecast for Antacids Market Share by Distribution Channel (Percent), 2023 - 2027
  • Table-07: Global - Antacids Market Share by Regions (Percent), 2017 - 2022
  • Table-08: Global - Forecast for Antacids Market Share by Regions (Percent), 2023 - 2027